**Haemophilia Wales Trustees Annual Report** : November 1[st] 2021-31[st] October 2022 Haemophilia Wales continues to provide information and support to patients and families in Wales. We keep in regular contact with members to ensure any new developments and issues are raised with staff and local Health Boards. We have regular meetings with North Wales patients and staff at the North Wales Operational and Strategic Group meetings and Expert Patient Forum meetings. We keep in close contact with Members of the Senedd and MPs to ensure our voices are heard at the Welsh Assembly and Westminster. Our meetings with the Cross Party Group on Haemophilia and Contaminated Blood Chaired by Rhun Ap Iowerth MS are well supported by patients, families and members of the Senedd. The meetings provide a platform for patients to raise any concerns they may have about service provision in Wales and the Infected Blood Inquiry. This forum provides a vital voice to patients who are currently receiving treatment in Wales and to bereaved families continuing to fight for justice for infected blood. Haemophilia Wales has Core Participant status at the Infected Blood Inquiry and our lawyers at Watkins and Gunn are recognised legal representatives at the Inquiry. We have regular meetings throughout the year in preparation for our legal submission to the Infected Blood Inquiry recommendations. **Charity Name No (if any) Receipts and payments accounts CC16a For the period** 01/11/2021 31/10/2022 **To from** ## **Section A Receipts and payments** |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest**
**£**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**1,674**
**-**
**-**
**-**
**1,674**
**- 1,674**
**-**
**-**
**- 1,674**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Total funds**
**to the nearest £**
**-**
**-**
**1,433**
**-**
**-**
**-**
**-**
**-**
**1,433**
**-**
**-**
**-**
**1,433**
**267**
**-**
**-**
**750**
**441**
**216**
**-**
**-**
**-**
**1,674**
**-**
**-**
**-**
**1,674**

**1,674**|**Total funds**
**to the nearest £**
**-**
**-**
**1,433**
**-**
**-**
**-**
**-**
**-**
**1,433**
**-**
**-**
**-**
**1,433**
**267**
**-**
**-**
**750**
**441**
**216**
**-**
**-**
**-**
**1,674**
**-**
**-**
**-**
**1,674**

**1,674**|**Last year**
**to the nearest £**| |---|---|---|---|---|---|---| |VoluntaryIncome|**-**|||||**-**| |Grants|**-**|||||**-**| |Donations|**-**|||||**730**| |Interest|**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| |**_Sub total_**_(Gross income for_
_AR)_|**-**|||||**730**| |||||||| |**A2 Asset and investment sales,**
**(see table).**||||||| ||**-**|||||| ||**-**|||||**-**| |**_Sub total_**|**-**|||||**-**| |**_Total receipts_**
**A3 Payments**||||||| |||||||**730**| |||||||| |Administration|**-**|||||**565**| |Gifts to Haemophilia Centre|**-**|||||**1,969**| |website|**-**|||||**160**| |HardshipGrants|**-**|||||**-**| |Travel expenses|**-**|||||**-**| |Funeral donations|**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| |**_Sub total_ **|**1,674**|||||**2,674**| |||||||| |**A4 Asset and investment**
**purchases, (see table)**||||||| ||**-**|||||| ||**-**|||||| |**_Sub total_ **|**-**|||||**-**| |**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**||||||| |||||||**2,674**| |||||||| ||**- 1,674**|**-**|**-**|
**1,674**||**- 1,944**| ||**-**|**-**|**-**|**-**||**-**| ||**-**|**-**|**-**|**-**||**-**| ||**- 1,674**|**-**|**-**|**2,985**||**3,226**| CCXX R1 accounts (SS) 1 ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B1 Cash funds**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B5 Liabilities**
**B3 Investment assets**|Signature
**Details**
**Details**
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
Agreement Error
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name|**Endowment**
**funds**
**to nearest £**| |---|---|---|---| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| ||||| ||||| CCXX R2 accounts (SS) 2